Science 37 Holdings Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

ended 09/30/22 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Thermo Fisher Scientific Inc, Thermo Fisher Scientific Powder Holdings III, Spectra-Physics Holdings USA, LLC, Thermo Fisher Scientific Powder Holdings I, Thermo Fisher Scientific Powder Holdings II, Fisher Scientific Worldwide Inc., Fisher Scientific International LLC

Thermo Fisher Scientific Inc, Pharmaceutical Product Development, LLC, Jaguar Holding Co I, LLC, Wildcat Acquisition Holdings (UK) Ltd, Eagle Holding Co II, LLC, Jaguar Holding Co II, PPD Inc, Thermo Fisher Scientific Powder US Holdings Corp., Thermo Fisher Scientific Powder Holdings IV, Thermo Fisher Scientific Powder US Holdings Ltd

Thermo Fisher Scientific Inc, Thermo Fisher Scientific Powder US Holdings Corp., Thermo Fisher Scientific Powder Holdings III, Spectra-Physics Holdings USA, LLC, Thermo Fisher Scientific Powder Holdings I, Thermo Fisher Scientific Powder Holdings IV, Thermo Fisher Scientific Powder Holdings II, Fisher Scientific Worldwide Inc., Thermo Fisher Scientific Powder US Holdings Ltd, Fisher Scientific International LLC

Thermo Fisher Scientific Inc

Faulkner Robert C.

News Filter

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Cost of Exit or Disposal Activities

To Be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Announces 1-For-20 Reverse Stock Split Effective December 8, 2023

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC